Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 47

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 47
---
 in the successful defense of any action, suit or proceeding) is            
 asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless          
 in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the             
 question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final         
 adjudication of such issue.                                                                                                                       |

| (i) | The undersigned registrant hereby undertakes that: |

| (1) | For purposes of determining any liability under the Securities Act, the information omitted from the form                           
 of prospectus filed as part of this Registration Statement in reliance upon Rule 430A and contained in the form of prospectus filed 
 by the registrant pursuant to Rule 424(b)(l) or (4) or 497(h) under the Securities Act shall be deemed to be a part                 
 of the Registration Statement as of the time it was declared effective.                                                             |

| (2) | For the purpose of determining any liability under the Securities Act, each post-effective amendment that                                     
 contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering 
 of such securities at that time shall be deemed to be the initial bona fide offering thereof.                                                 |

| (j) | The undersigned registrant hereby undertakes to file an application for the purpose of determining the                     
 eligibility of the trustee to act under subsection (a) of section 310 of the Trust Indenture Act (the “Act”) in accordance 
 with the rules and regulations prescribed by the Commission under section 305(b)(2) of the Act.                            |

<div align='center'>II-3

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing
on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized,
in the City of Los Angeles, State of California, on August 13, 2025.

| ARMATA                
 PHARMACEUTICALS, INC. |                         |
| By:                   | /s/                     
 Deborah L. Birx, M.D.   |
|                       | Deborah                 
 L. Birx, M.D.           |
|                       | Chief Executive